Topic
SpaceX Research
Current institutional research highlights a market environment that prioritizes private equity and large-scale technological infrastructure, both of which are central to the SpaceX narrative. While Goldman Sachs reports aggressive selling within the Industrials sector, there is a persistent institutional appetite for private markets as diversifiers that offer higher returns and lower volatility than traditional public indices. This focus on private assets is increasingly relevant as BlackRock emphasizes a 'speed and scarcity' theme, particularly regarding the projected $1 trillion annual AI infrastructure buildout. Despite potential headwinds from hawkish Federal Reserve policies and high institutional leverage reaching five-year peaks, there remains a tactical preference for U.S. equities and technology beneficiaries. Additionally, the development of liquid private equity investment vehicles is bridging the gap for retail access to historically illiquid segments of the market. Consequently, the research suggests that while the broader industrial sector faces selling pressure, capital continues to flow toward high-growth, private-market leaders that define the next generation of technological expansion.
4204 reports available
All reports
Page 16 of 176
Multi-Asset Strategy Daily
Mizuho International · Jul 1, 2026
TMT Specialist Sales Market Update
Goldman Sachs · Jul 1, 2026
The Point for Europe
Citi · Jul 1, 2026
FX Risk Index
Crédit Agricole Corporate and Investment Bank · Jul 1, 2026
AI IPOs: Why They Will Change the Boom Forever
Deutsche Bank Research Institute · Jul 1, 2026
Meta A Silver Lining
Deutsche Bank · Jul 1, 2026
Quarterly Updates
UniCredit · Jul 1, 2026
GEMs Equity Navigator
HSBC · Jul 1, 2026
Williams Cos. 2Q26 Preview
Goldman Sachs · Jul 1, 2026
GS Sustain Notes From The Road
Goldman Sachs · Jul 1, 2026
Who Cares What Warsh Thinks
TS Lombard · Jul 1, 2026
Themes And Baskets For 2H26
Goldman Sachs · Jul 1, 2026
Middle East Daily
MUFG Securities, Inc & MUFG Bank, Ltd. · Jul 1, 2026
Japan FX Nobody Stopping Yen Depreciation
Citi · Jul 1, 2026
Top Stories
Goldman Sachs · Jul 1, 2026
US Conviction List Update
Goldman Sachs · Jul 1, 2026
US Equities Color: Unwindy
Goldman Sachs & Co. LLC · Jul 1, 2026
Guardant Health Inc. UnitedHealth Policy Coverage Decision on GH Shield Test
Goldman Sachs · Jul 1, 2026
Market Intelligence US Morning Update
Goldman Sachs · Jul 1, 2026
US Conviction List Directors Cut July 2026 Spotlight
Goldman Sachs · Jul 1, 2026
Macro at a Glance
Goldman Sachs · Jul 1, 2026
At the Edge of the Developer Ecosystem: Observations in and Around Vercel Ship
Goldman Sachs · Jul 1, 2026
The Cigna Group: AI Investment in Accredo Specialty Pharmacy
Goldman Sachs · Jul 1, 2026
US Market Thematics Specialist Sales Commentary
J.P. Morgan · Jul 1, 2026